Literature DB >> 8177023

A simple and precise method for the routine determination of platelet-activating factor in blood and urine.

C A Demopoulos1, N K Andrikopoulos, S Antonopoulou.   

Abstract

A simple and precise method is described for the measurement of platelet-activating factor (PAF) in blood and urine. The method involves the isolation of PAF from blood samples by two successive steps. In the first step, blood proteins are precipitated with ethanol and the "free" PAF, i.e., the PAF which is extractable with ethanol, is recovered. In the second step, "bound" PAF, i.e., PAF not extractable with ethanol, is extracted from the protein precipitate with chloroform/methanol/water. The extraction of PAF from urine samples requires only the ethanol extraction step. "Free" and "bound" PAF are then each fractionated by silicic acid column chromatography, and the methanol/water eluent containing PAF is then further fractionated by high-performance liquid chromatography using an isocratic solvent system of acetonitrile/methanol/water. PAF is then quantitated by measuring its ability to induce platelet aggregation in an aggregometer. Application of the method to blood and urine samples from twenty-three healthy volunteers revealed PAF levels in blood of 140-480 pg/mL (630-254.4 pg "free" PAF/mL and 64-225.6 pg "bound" PAF/mL), and of 1.2-4.0 pg PAF/mL in urine. The method overcomes various technical problems and was shown to be very precise. It should prove useful for monitoring PAF levels in various disease conditions.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8177023     DOI: 10.1007/bf02536336

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  20 in total

1.  The platelet-activating factor acetylhydrolase from human plasma prevents oxidative modification of low-density lipoprotein.

Authors:  D M Stafforini; G A Zimmerman; T M McIntyre; S M Prescott
Journal:  Trans Assoc Am Physicians       Date:  1992

Review 2.  Inflammatory mediators and asthma.

Authors:  P J Barnes; K F Chung; C P Page
Journal:  Pharmacol Rev       Date:  1988-03       Impact factor: 25.468

3.  Preformed PAF-acether and lyso PAF-acether are bound to blood lipoproteins.

Authors:  J Benveniste; D Nunez; P Duriez; R Korth; J Bidault; J C Fruchart
Journal:  FEBS Lett       Date:  1988-01-04       Impact factor: 4.124

4.  High-performance liquid chromatographic analysis of platelet activating factor on a cation-exchange column by direct ultraviolet detection.

Authors:  N K Andrikopoulos; C A Demopoulos; A Siafaka-Kapadai
Journal:  J Chromatogr       Date:  1986-08-29

5.  Antihypertensive activity of an alkyl ether analog of phosphatidylcholine.

Authors:  M L Blank; F Snyder; L W Byers; B Brooks; E E Muirhead
Journal:  Biochem Biophys Res Commun       Date:  1979-10-29       Impact factor: 3.575

6.  PAF of biological fluids in disease: blood levels in allergic rhinitis.

Authors:  K Labrakis-Lazanas; M Lazanas; S Koussissis; S Tournis; C A Demopoulos
Journal:  Haematologica       Date:  1988 Sep-Oct       Impact factor: 9.941

7.  Solid-phase extraction on silica cartridges as an aid to platelet-activating factor enrichment and analysis.

Authors:  D R Janero; C Burghardt
Journal:  J Chromatogr       Date:  1990-03-16

8.  Increased levels of platelet-activating factor in blood from patients with cirrhosis of the liver.

Authors:  C Caramelo; S Fernández-Gallardo; J C Santos; P Iñarrea; M Sánchez-Crespo; J M López-Novoa; L Hernando
Journal:  Eur J Clin Invest       Date:  1987-02       Impact factor: 4.686

9.  Paf-acether production by Escherichia coli.

Authors:  Y Denizot; E Dassa; J Benveniste; Y Thomas
Journal:  Biochem Biophys Res Commun       Date:  1989-06-15       Impact factor: 3.575

10.  Presence of platelet-activating factor in blood from humans and experimental animals. Its absence in anephric individuals.

Authors:  C Caramelo; S Fernández-Gallardo; D Marín-Cao; P Iñarrea; J C Santos; J M López-Novoa; M Sanchez Crespo
Journal:  Biochem Biophys Res Commun       Date:  1984-05-16       Impact factor: 3.575

View more
  10 in total

1.  Circulating platelet-activating factor is primarily cleared by transport, not intravascular hydrolysis by lipoprotein-associated phospholipase A2/ PAF acetylhydrolase.

Authors:  Jinbo Liu; Rui Chen; Gopal K Marathe; Maria Febbraio; Weilin Zou; Thomas M McIntyre
Journal:  Circ Res       Date:  2010-12-23       Impact factor: 17.367

2.  Effects of eccentric exercise-induced muscle injury on blood levels of platelet activating factor (PAF) and other inflammatory markers.

Authors:  George A Milias; Tzortzis Nomikos; Elizabeth Fragopoulou; Spyridon Athanasopoulos; Smaragdi Antonopoulou
Journal:  Eur J Appl Physiol       Date:  2005-09-06       Impact factor: 3.078

3.  Platelet-activating factor and P-selectin activities in thrombotic and nonthrombotic Behçet's patients.

Authors:  S Ercan Tunc; Kenan Aksu; Gokhan Keser; Fahrettin Oksel; Eker Doganavsargil; Timur Pirildar; Tufan Turk; Ender Terzioglu; Afig Huseyinov
Journal:  Rheumatol Int       Date:  2004-03-05       Impact factor: 2.631

4.  Platelet-activating factor involvement in thioacetamide-induced experimental liver fibrosis and cirrhosis.

Authors:  Haralabos C Karantonis; Georgios Gribilas; Ioannis Stamoulis; Constantinos Giaginis; Chara Spiliopoulou; Gregorios Kouraklis; Constantinos Demopoulos; Stamatios E Theocharis
Journal:  Dig Dis Sci       Date:  2009-02-26       Impact factor: 3.199

5.  Platelet activating factor levels and metabolism in Tangier disease: a case study.

Authors:  Vana Kolovou; Vasiliki D Papakonstantinou; George Stamatakis; Sophia N Verouti; Marianna N Xanthopoulou; Genovefa Kolovou; Constantinos A Demopoulos
Journal:  Lipids Health Dis       Date:  2012-07-08       Impact factor: 3.876

6.  Fish polar lipids retard atherosclerosis in rabbits by down-regulating PAF biosynthesis and up-regulating PAF catabolism.

Authors:  Constantina Nasopoulou; Alexandros B Tsoupras; Haralabos C Karantonis; Constantinos A Demopoulos; Ioannis Zabetakis
Journal:  Lipids Health Dis       Date:  2011-11-16       Impact factor: 3.876

7.  Is there an interplay between the SARS-CoV-2 spike protein and Platelet-Activating factor?

Authors:  Smaragdi Antonopoulou; Filio Petsini; Maria Detopoulou; Theoharis C Theoharides; Constantinos A Demopoulos
Journal:  Biofactors       Date:  2022-07-19       Impact factor: 6.438

8.  Hydroxyl-platelet-activating factor exists in blood of healthy volunteers and periodontal patients.

Authors:  Smaragdi Antonopoulou; Alexandros Tsoupras; George Baltas; Helen Kotsifaki; Zacharias Mantzavinos; Constantinos A Demopoulos
Journal:  Mediators Inflamm       Date:  2003-08       Impact factor: 4.711

9.  Antithrombotic and antiatherosclerotic properties of olive oil and olive pomace polar extracts in rabbits.

Authors:  Nektaria Tsantila; Haralabos C Karantonis; Despina N Perrea; Stamatios E Theocharis; Dimitrios G Iliopoulos; Smaragdi Antonopoulou; Constantinos A Demopoulos
Journal:  Mediators Inflamm       Date:  2007       Impact factor: 4.711

10.  In vivo effect of two first-line ART regimens on inflammatory mediators in male HIV patients.

Authors:  Vasiliki D Papakonstantinou; Maria Chini; Nikos Mangafas; George M Stamatakis; Nickolaos Tsogas; Alexandros B Tsoupras; Katherina Psarra; Elizabeth Fragopoulou; Smaragdi Antonopoulou; Panagiotis Gargalianos; Constantinos A Demopoulos; Marios-C Lazanas
Journal:  Lipids Health Dis       Date:  2014-05-29       Impact factor: 3.876

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.